Texas DSHS HIV/STD Program - Texas HIV Medication Program

THMP Moving Forward Together Partnership

The Texas HIV Medication Program (THMP) provides medications for the treatment of HIV and its related complications for low-income Texans. To qualify for medications, potential clients who meet eligibility criteria complete an application for assistance. Once approved, a client receives medications at an assigned pharmacy in their community.

To learn more about the THMP and find out if you are eligible, see the Frequently Asked Questions. You can apply for the program by downloading and completing the client application. Be sure and review the specific “application instructions” when completing the application. The application and its instructions are located on the THMP document page. If you have more questions or need assistance completing your application, call the THMP toll free at 1-800-255-1090.

The THMP is the official AIDS Drug Assistance Program (ADAP) for the State of Texas. The THMP has been in existence since 1987 and provides medications approved by the Food and Drug Administration (FDA) for the treatment of illnesses caused by the human immunodeficiency virus (HIV) and other opportunistic infections in HIV-infected individuals as prescribed by their doctor. THMP also operates the Texas HIV State Pharmaceutical Assistance Program (SPAP) which helps HIV-positive individuals that do not qualify for the full Low-Income Subsidy (extra help) with their out-of-pocket costs associated with Medicare Part D prescription drug plans, including co-payments, deductibles, coinsurance, and during the coverage gap (the "donut hole").

Texas HIV Medication Program Medication Advisory Committee Meeting November 5, 2021

November 5, 2021 - 1:30 p.m.

Meeting Site: Texas Health and Human Services Commission, John H. Winters Building, Public Hearing Room 125, First Floor, 701 West 51st Street, Austin, Texas 78751

This meeting will be webcast. Members of the public may attend the meeting in person at the address above or access a live stream of the meeting at https://texashhsmeetings.org/HHSWebcast. Select the tab for the Winters Public Hearing Room Live on the date and time for this meeting. Please e-mail Webcasting@hhsc.state.tx.us if you have any problems with the webcasting function.

This meeting will also be conducted via videoconference call in accordance with the requirements of Section 551.127, Government Code. The member of the Committee presiding over the meeting will be physically present at the location specified above.

Attendees who would like to provide public comment should see the Public Comment section below.

Agenda

Call to Order and Welcome – Natalie Vanek, M.D., Committee Chair
Logistical Announcement and Roll Call – Sallie Allen, Advisory Committee Coordination Office, HHSC
Consideration of July 30, 2021, Meeting Minutes (Vote Required) – Sallie Allen, Advisory Committee Coordination Office, HHSC
Department of State Health Services updates – Imelda Garcia, MPH Associate Commissioner of Laboratory and Infectious Disease Services (LIDS)
1. Staffing Updates
2. HIV Budget report
3. September 29, 2021 Partnership meeting summary update
THMP Update - Rachel Sanor, THMP Manager
1. MAC appointment process
2. THMP - Projections and Demographic information
3. THMP backlog
4. Spend down suspension
5. 90-day supply analysis
Pharmacy Annual Inventory Update & Report – Joshua Hutchison, Pharmacy Director
Election of Officers – Sallie Allen, Advisory Committee Coordination Office, HHSC
Subcommittee reports
1. Governance/Data – Nancy Miertschin
2. Eligibility – Frank Rosas
3. Formulary Sub-committee – Natalie Vanek, M.D.
  1. Impact of suspended medications
  2. Recommendation to approve pediatric medications
    1. Raltegravir 25mg (new dosage)
    2. Tivicay (new dosage)
Committee to vote on addition of Raltegravir 25 mg and Tivicay PD to THMP formulary (Vote Required)
Public Comment – Sallie Allen, Advisory Committee Coordination Office, HHSC
Action items and agenda topics for next scheduled meeting: January 22, 2022 – Natalie Vanek, M.D., Committee Chair
Adjourn – Natalie Vanek, M.D., Committee Chair

Public Comment: The Department of State Health Services (DSHS) welcomes public comments pertaining to topics related to the Texas HIV Medication Program. Members of the public who would like to provide public comment may choose from the following options:

Oral comments provided virtually: Members of the public must pre-register to provide oral comments virtually during the meeting by completing a Public Comment Registration form at https://texashhsmeetings.org/THMPMAC_PCReg_Nov2021 no later than 5:00 p.m. Wednesday, November 3, 2021. Please mark the correct box on the Public Comment Registration form and provide your name, either the organization you are representing or that you are speaking as a private citizen, and your direct phone number. If you have completed the Public Comment Registration form, you will receive an email the day before the meeting with instructions for providing virtual public comment. Public comment is limited to three minutes. Each speaker providing oral public comments virtually must ensure their face is visible and their voice audible to the other participants while they are speaking. Each speaker must state their name and on whose behalf they are speaking (if anyone). If you pre-register to speak and wish to provide a handout before the meeting, please submit an electronic copy in accessible PDF format that will be distributed by HHS staff to THMP-MAC members and State staff. Handouts are limited to two pages (paper size: 8.5” by 11”, one side only). Handouts must be emailed to Mary.Richards@dshs.texas.gov immediately after pre-registering, but no later than 5:00 p.m. Wednesday, November 3, 2021, and include the name of the person who will be commenting. Do not include health or other confidential information in your comments or handouts. Staff will not read handouts aloud during the meeting, but handouts will be provided to THMP-MAC members and State staff.
Written comments: Members of the public may provide written public comments by completing a Public Comment Registration form at https://texashhsmeetings.org/THMPMAC_PCReg_Nov2021. A member of the public who wishes to provide written public comments must email the comments to Mary.Richards@dshs.texas.gov no later than 5:00 p.m. Wednesday, November 3, 2021. Please include your name and the organization you are representing or that you are speaking as a private citizen. Written comments must be emailed to DSHS immediately after pre-registering and include the name of the person who will be commenting. Written comments are limited to two pages (paper size: 8.5” by 11”, one side only). Do not include health or other confidential information in your comments. Staff will not read written comments aloud during the meeting, but comments will be provided to THMP-MAC members and State staff.
Oral comments provided in-person at the meeting location: Members of the public may provide oral public comment during the meeting in person at the meeting location either by pre-registering using the form above or without pre-registering by completing a form at the entrance to the meeting room. Do not include health or other confidential information in your comments.

Note: These procedures may be revised at the discretion of HHSC.

Contact: Questions regarding agenda items, content, or meeting arrangements should be directed to Mary Richards, Pharmacy Coordinator, Department of State Health Services, at Mary.Richards@dshs.texas.gov or via phone at 1-800-255-1090.

This meeting is open to the public. No reservations are required, and there is no cost to attend this meeting.

People with disabilities who wish to attend the meeting and require assistive technology or services should contact Mary Richards, at Mary.Richards@dshs.texas.gov, or 800-255-1090 at least 72 hours prior to the meeting so that appropriate arrangements can be made.